Company Overview

Company Overview |  Leadership | Scientific Advisory Board

 

VCANBIO Cell & Gene Engineering Corporation, Ltd. is a top Chinese biotech company, focusing on cell therapy, precision medicine and other related fields. Publicly traded on the Shanghai Stock Exchange, VcanBio was the first company to offer storage of cord blood in China. Additionally, VcanBio has the largest cord blood banks in the world, with over 300,000 cord blood units.VcanBio also owns several subsidiary biotech companies, including Union Stem Cell & Gene Engineering Co., Ltd., Alliancells Bioscience Co., Ltd., Zhongyuan Union Gene Technology Co., Ltd., Zhongyuan Pharma Co., Ltd., and Shanghai Zhicheng Biological Technology Co., Ltd.

VcanBio also owns several subsidiary biotech companies, including Union Stem Cell & Gene Engineering Co., Ltd., Alliancells Bioscience Co., Ltd., Zhongyuan Union Gene Technology Co., Ltd., Zhongyuan Pharma Co., Ltd., and Shanghai Zhicheng Biological Technology Co., Ltd.

To extend its operation worldwide, VcanBio recently established its two subsidiaries in the United States: VCANBIO USA Co. Ltd. and VcanBio Center for Translational Biotechnology, both of which are located at 21 Strathmore Road, Natick, Massachusetts. VcanBio USA focuses on investing in cell and immunotherapy areas in North America, while the fundamental goal of the Center for Translational Biotechnology (“CTB”) is to function as a service entity. CTB aims to foster the advance of promising biologics, treatments, and new therapies, through partnership and co-development. To do this, CTB locates and provides the infrastructure, expertise and resources necessary to identify and evaluate innovative projects and programs at various stages of clinical translation. Additionally, CTB performs tests and offers support for preclinical investigation, clinical trial submission, and trial implementation.

CTB is led by the esteemed Shi-Jiang Lu, Ph.D, MPH, the president and CEO of the subsidiary. Dr. Lu has directed preclinical stem cell researches and clinical studies, both basic and translational. He is an expert in stem cell biology and regenerative medicine with 20 years of experience.